The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of sequential therapies (txs) in patients (pts) with castration resistant prostate cancer (CRPC) previously treated with galeterone.
 
Rana R. McKay
Research Funding - Bayer; Pfizer
 
Lillian Werner
No Relationships to Disclose
 
Matthew Fiorillo
No Relationships to Disclose
 
Kathryn Dumas
No Relationships to Disclose
 
Jennifer Roberts
Employment - Infinity Pharmaceuticals; Tokai Pharmaceuticals
Stock and Other Ownership Interests - Infinity Pharmaceuticals; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Infinity Pharmaceuticals; Tokai Pharmaceuticals
 
Khalid Mamlouk
Employment - Tokai Pharmaceuticals
Stock and Other Ownership Interests - Tokai Pharmaceuticals
 
Mary-Ellen Taplin
Honoraria - Bayer; Dendreon; Janssen-Ortho; Medivation; Tokai Pharmaceuticals
Consulting or Advisory Role - Bayer; Best Doctors, Inc; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen-Ortho; Medivation; Sanofi; Tokai Pharmaceuticals; UpToDate
Research Funding - Bayer; Genentech; Janssen-Ortho; Medivation
Travel, Accommodations, Expenses - Dendreon; Janssen Oncology; Medivation; Tokai Pharmaceuticals